Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10407	Companies
217577	Keywords
147140	Articles
115139	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 02/24/2025 at 11:26, 1 year 2 months ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates its research on Formycon AG, maintaining a Buy recommendation with a decreased target price from EUR 82 to EUR 46 due to higher price pressure and reduced investments in biosimilar portfolio

First Berlin Equity Research Buy Recommendation Research Update Formycon AG Biosimilar Portfolio
BRIEF

published on 02/20/2025 at 06:35, 1 year 2 months ago

Formycon dévoile les données cliniques du biosimilaire d'ustekinumab FYB202 au congrès de l'ECCO

Formycon AG FYB202 Biosimilaire Approbation Réglementaire Données Cliniques
BRIEF

published on 02/20/2025 at 06:35, 1 year 2 months ago

Formycon Unveils Clinical Data for Ustekinumab Biosimilar FYB202 at ECCO Congress

Formycon AG Regulatory Approval Clinical Data Biosimilar FYB202
PRESS RELEASE

published on 02/20/2025 at 06:30, 1 year 2 months ago

Formycon presents clinical data on ustekinumab biosimilar FYB202 at the ECCO Congress in Berlin
Formycon presents clinical data on ustekinumab biosimilar FYB202 at ECCO Congress, demonstrating comparability with Stelara. FYB202 approved in multiple regions

Clinical Data ECCO Congress Biosimilar Formycon Ustekinumab
BRIEF

published on 02/17/2025 at 09:32, 1 year 2 months ago

Formycon AG Updates on Biosimilar Projects and Strategic Adjustments

FDA Approval Biosimilars Financial Adjustments Commercial Strategy Price Discounts
BRIEF

published on 02/17/2025 at 09:32, 1 year 2 months ago

Formycon AG fait le point sur ses projets biosimilaires et ses ajustements stratégiques

Stratégie Commerciale Approbation De La FDA Biosimilaires Ajustements Financiers Réductions De Prix
PRESS RELEASE

published on 02/17/2025 at 09:27, 1 year 2 months ago

Formycon AG informs about recent developments in various biosimilar projects and invites to conference call
Formycon AG provides updates on various biosimilar projects, including terminating phase III trial for FYB206. Conference call on Feb 17, 2025, to discuss recent developments

FDA Conference Call Formycon AG FYB206 Biosimilar Projects
BRIEF

published on 02/17/2025 at 08:10, 1 year 2 months ago

Formycon Updates on Phase III Trial and Valuation Adjustments

Formycon AG FDA Feedback Phase III Trial Commercialization Strategy Biosimilar Valuation
BRIEF

published on 02/17/2025 at 08:10, 1 year 2 months ago

Formycon fait le point sur l'essai de phase III et les ajustements de valorisation

Formycon AG Stratégie De Commercialisation Essai De Phase III Commentaires De La FDA Évaluation Des Biosimilaires
PRESS RELEASE

published on 02/17/2025 at 08:05, 1 year 2 months ago

EQS-Adhoc: Formycon announces decision on Phase III trial with FYB206 and provides update on potential need to adjust the valuation of FYB202 and FYB201
Formycon terminates Phase III trial for FYB206 after FDA feedback, anticipates valuation adjustments for FYB202 & FYB201 due to price discounts

FDA Feedback Valuation Adjustments Formycon FYB206 Price Discounts

Accesswire

Published on 05/14/2026 at 18:00, 30 minutes ago

AIAI Holdings Corporation Begins Trading on NASDAQ Under Ticker 'AIAI'
Published on 05/14/2026 at 17:10, 1 hour 20 minutes ago

Namibia Critical Metals Announces Results of Annual General Meeting of Shareholders and Issuance of Options
Published on 05/14/2026 at 15:10, 3 hours 20 minutes ago

Banyan Provides Summary of 2025 Diamond Drill Program for the Flagship AurMac Project, Yukon, Canada
Published on 05/14/2026 at 15:00, 3 hours 30 minutes ago

Karbon-X Explores Clean Cooking and Fish Smoking Climate Initiative Concept in Senegal
Published on 05/14/2026 at 15:00, 3 hours 30 minutes ago

ACCESS Newswire Celebrates PRSSA Bateman Competition Success and the Next Generation of Communications Leaders

View all ACCESSWIRE

EQS Group

Published on 05/14/2026 at 17:05, 1 hour 25 minutes ago

YAS ISLAND TO BE HOME OF SPHERE ABU DHABI, A NEW GLOBAL ICON FOR IMMERSIVE ENTERTAINMENT
Published on 05/14/2026 at 16:55, 1 hour 35 minutes ago

CGTN: 'Constructive strategic stability': China, US eye new vision for ties
Published on 05/14/2026 at 16:15, 2 hours 15 minutes ago

Fibank successfully closed a record-breaking international placement for a Bulgarian bank, raising a total of EUR 310 million across two bond issues
Published on 05/14/2026 at 14:55, 3 hours 35 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 05/14/2026 at 14:54, 3 hours 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc

Les Echos

Published on 05/14/2026 at 09:03, 9 hours 27 minutes ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 1 day ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 1 day ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 18:00, 1 day ago

DDV declaration au 30 avril 2026
Published on 05/13/2026 at 18:00, 1 day ago

ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires

View all LES ECHOS COMFI WIRE